Is AI coming for my job? It’s not uncommon to wonder these days. 

What if AI could just read a press release and appreciate the value of a stock at least as well as I think I can? Might not be a big jump from there to AI opening up its own biotech fund. 

But before I ceded my job to ChatGPT, I figured I would at least take it for a test drive by having it analyze a press release from a company I knew well.

The biotech sector is experiencing the most severe downturn of at least the last 20 years. There have been many other downturns in the more recent past, but this one is different. Here Peter Kolchinsky discusses why - and how we’ll rebound.

When a biotech company is valued at around the same amount of cash it has sitting in the bank, is it a safe investment? Some investors might think so - and so we looked at the data. The answer might surprise you.